A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

COLUMBIA SC (WOLO) – We all understand the importance of the heart, but there are some other afflictions related to the ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients ...

Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.